Effects of 1-methyl-4-phenylpyridinium on radioligand binding to the NMDA receptor complex

Res Commun Mol Pathol Pharmacol. 1995 May;88(2):131-6.

Abstract

The present study was performed to determine if 1-methyl-4-phenylpyridinium (MPP+) affects binding of [3H](-)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imi ne maleate ([3H]MK-801), [3H]glutamate and [3H]glycine to the rat and monkey striatal N-methyl-D-aspartate (NMDA) receptor. We found that MPP+ non-competitively inhibits [3H]MK-801 binding with IC50 values between 80 and 330 microM depending on the species and the concentration of glutamate and glycine. MPP+ also partially inhibited [3H]glycine binding without affecting [3H]glutamate binding. We conclude that MPP+ is not an agonist at the NMDA receptor but at high concentrations inhibits NMDA receptor function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / toxicity*
  • Animals
  • Dizocilpine Maleate / metabolism
  • Glutamic Acid / metabolism
  • Glycine / metabolism
  • Macaca fascicularis
  • Male
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate / drug effects*
  • Receptors, N-Methyl-D-Aspartate / metabolism

Substances

  • Receptors, N-Methyl-D-Aspartate
  • Glutamic Acid
  • Dizocilpine Maleate
  • 1-Methyl-4-phenylpyridinium
  • Glycine